Ovira is a women's healthcare platform that utilizes transcutaneous electrical nerve stimulation (TENS) technology to provide targeted pain relief for menstrual cramps. This device offers a non-invasive solution to alleviate discomfort, improving the quality of life for users during their menstrual cycle.
Funding
$1.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many women experience significant discomfort and pain, such as menstrual cramps, bloating, skin issues, and cravings, which can negatively impact their daily lives and overall well-being. Traditional methods of managing these symptoms may not always be effective or convenient.
Solution
Ovira provides science-backed supplements designed to address common women's health concerns, including cravings, bloating, and skin issues. Their product line focuses on high-quality ingredients and formulations to ensure optimal absorption and effectiveness. By offering targeted solutions for specific symptoms, Ovira aims to improve women's gut and hormone health, helping them feel better and live in harmony.
Target Audience
Ovira's primary customers are women seeking natural and effective solutions to manage cravings, bloating, skin issues, and other common health concerns related to gut and hormone health.
Features
- Formulated with science-backed ingredients
- Manufactured in the USA and Australia
- Vegan-friendly options available
- Free of artificial colors and flavors
- Non-GMO
- Third-party lab tested
- Products include Curb Cravings, Bloat Control, and Skin Clear supplements
- Bundle options available for comprehensive support